Showing results (521-530 of 1,126) with videos related to
Sort By:
Pageof 113
Cancer Genetics|June 18, 2025
Comprehensive molecular profiling in MOTION studyOlesya A Kuznetsova, Maxim V Ivanov, Alexandra A Lebedeva, et al.Cancer Genetics|March 9, 2024
t(2;2;21;8)(p21;q37;q22;q22), a novel four-way complex translocation involving variant t(8;21) in case of acute myeloid leukemia : A case report and literature reviewBingbing Han, Yu Jing, Xiaoyu Bi, et al.Cancer Genetics|March 19, 2024
Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancerGabriel Arantes Dos Santos, Nayara I Viana, Ruan Pimenta, et al.Cancer Genetics|September 6, 2024
Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessmentLeila JahangiriCancer Genetics|August 30, 2024
BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screeningRojalin Nayak, Bibekanand MallickCancer Genetics|September 22, 2024
Dysregulation of metallothionein MT1 sub-types in TCF3::PBX1 pre-B-cell acute lymphoblastic leukemiaAditi Agnihotri, Vinesh S Kamble, Satyajeet P KhareCancer Genetics|October 25, 2024
Elucidating the prognostic and therapeutic significance of TOP2A in various malignanciesGuangchao Liu, Wenlong Lin, Kaifeng Zhang, et al.Cancer Genetics|May 20, 2025
Potential factors underlying the progression of RUNX1-mutated MDS to AMLAnna Stengel, Katharina Hörst, Constanze Kühn, et al.Cancer Genetics|May 3, 2025
Rab5if is a potential therapeutic target of NSCLCLinjuan Lu, Lixiu Chen, Feng Gao, et al.Cancer Genetics|March 28, 2025
Identification of new immune target and signaling for cancer immunotherapySakshi Narote, Sharav A Desai, Vipul P Patel, et al.Pageof 113